You are here

Article info

Article menu

Download PDFPDF

Recent advances in clinical practice
Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
Free

Authors

  • Yaron Rotman Liver and Energy Metabolism Unit, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Arun J Sanyal Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Yaron Rotman, Liver and Energy Metabolism Unit, Liver Diseases Branch, NIDDK, NIH, 10 Center Drive, Building 10, Room 9C434, MSC 1800, Bethesda, MD 20892-1800, USA; rotmany{at}niddk.nih.gov
View Full Text

Citation

Rotman Y, Sanyal AJ
Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
Gut 2017;66:180-190.

Publication history

  • Received June 13, 2016
  • Revised August 29, 2016
  • Accepted August 30, 2016
  • First published September 19, 2016.
Online issue publication 
July 07, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/